Cryoablation for the Treatment of Residual or Recurrent Disease After Prior Microwave Ablation of Renal Cell Carcinoma

B M Aarts^{1

2}, T R Baetens³, D Corominas Munoz⁴, S F Oudkerk³, A M Solouki³, A D Horsch³, A Bex^{5

6}, R G H Beets-Tan^{3

7}, E G Klompenhouwer⁸, F M Gómez^{3

4}

Affiliations

¹ Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. b.aarts@nki.nl.
² GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands. b.aarts@nki.nl.
³ Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
⁴ Department of Interventional Radiology, Hospital Clinic Universitari de Barcelona, Carrer de Villarroel 170, 08036, Barcelona, Spain.
⁵ Department of Urology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
⁶ Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust and UCL Division of Surgery and Interventional Science, Pond Street, London, NW3 2QG, UK.
⁷ GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands.
⁸ Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. l.klompenhouwer@nki.nl.

B M Aarts et al. Cardiovasc Intervent Radiol. 2021 Jul.

. 2021 Jul;44(7):1144-1146.

doi: 10.1007/s00270-021-02811-7. Epub 2021 Mar 15.

B M Aarts^{1

2}, T R Baetens³, D Corominas Munoz⁴, S F Oudkerk³, A M Solouki³, A D Horsch³, A Bex^{5

6}, R G H Beets-Tan^{3

7}, E G Klompenhouwer⁸, F M Gómez^{3

4}

¹ Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. b.aarts@nki.nl.
² GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands. b.aarts@nki.nl.
³ Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
⁴ Department of Interventional Radiology, Hospital Clinic Universitari de Barcelona, Carrer de Villarroel 170, 08036, Barcelona, Spain.
⁵ Department of Urology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
⁶ Specialist Centre for Kidney Cancer, Royal Free London NHS Foundation Trust and UCL Division of Surgery and Interventional Science, Pond Street, London, NW3 2QG, UK.
⁷ GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands.
⁸ Department of Radiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. l.klompenhouwer@nki.nl.

No abstract available

References

1. Aarts BM, Prevoo W, Meier MAJ, et al. Percutaneous microwave ablation of histologically proven T1 renal cell carcinoma. Cardiovasc Interv Radiol. 2020;43(7):1025–33. - DOI
1. Janzen NK, Perry KT, Han KR, et al. The effects of intentional cryoablation and radio frequency ablation of renal tissue involving the collecting system in a porcine model. J Urol. 2005;173(4):1368–74. - DOI
1. Kowalczyk KJ, Hooper HB, Linehan WM, Pinto PA, Wood BJ, Bratslavsky G. Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J Urol. 2009;182(5):2158–63. - DOI
1. Matin SF, Ahrar K, Cadeddu JA, et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006;176(5):1973–7. - DOI
1. Sundelin MO, Lagerveld B, Ismail M, Keeley FX Jr, Nielsen TK. Repeated cryoablation as treatment modality after failure of primary renal cryoablation: a european registry for renal cryoablation multinational analysis. J Endourol. 2019;33(11):909–13. - DOI